Bioanalysis News and Research

RSS

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meetin

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

From MGI 14 Feb 2023

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

From Complete Genomics 9 Feb 2023

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

From Complete Genomics 9 Feb 2023

New biosensing platform detects SARS-CoV-2 antibodies in five minutes

Rapid, cheap and accurate tests continue to be essential for epidemiological surveillance and for health services to monitor and contain the spread of SARS-CoV-2. Brazilian scientists have contributed to endeavors in this field by developing an electrochemical immunosensor that detects antibodies against the virus.

29 Nov 2022

Synexa Life Sciences Strengthens its Executive Team for Further Growth

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, announces its plans for growth and the strengthening of its executive team.

From Synexa Life Sciences BV 15 Jun 2022

Syrinx Bioanalytics Acquired by Synexa Life Sciences to Expand Scope of Bioanalysis

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it has acquired Syrinx Bioanalytics, a bioanalytical CRO based in Turku, Finland.

From Synexa Life Sciences BV 15 Jun 2022

Synexa Life Sciences Opens New Rockville Laboratory Site in North America

Synexa Life Sciences recently opened new lab facilities in Rockville, Maryland (US) to work closely with US clients and provide a more extensive range of solutions, including Synexa’s industry-leading specialist flow cytometry services.

From Synexa Life Sciences BV 15 Jun 2022

Dual therapeutic potential of zapnometinib against COVID-19

Researchers assessed the impact of the drug zapnometinib on human immune response against coronavirus disease 2019.

2 Mar 2022

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.

From Malvern Panalytical 13 Jan 2022

Providing quick & efficient CRO services with Sino Biological

In this interview, News-Medical talks to Dr. Lin Yutao, head of project management at Sino Biological, about the work she does and how Sino provides quick and efficient recombinant CRO services.

From Sino Biological Inc. 15 Dec 2021

New, rapid antibody test gives detailed information on how the immune system reacts to Covid-19

A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to Covid-19 and other types of viruses and bacteria.

29 Dec 2020

Roundworm study suggests alternatives for treatment of schizophrenia

A group of Brazilian scientists have long conducted experiments with roundworms to investigate the role of schizophrenia-linked genes in patients' response to antipsychotic drugs. The results obtained thus far point to new ways of understanding resistance to certain classes of medication.

20 Mar 2019

A Light Source in Quantitative Analysis: What Role Does it Play?

In this interview, Claudia Jaffe discusses the importance of illuminators in microscopy and the different types of light used in life science research.

From Lumencor, Inc 7 Jan 2019

Highly sensitive ELISA method for analysis of CET in plasma samples

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.

23 Feb 2018

Multi-spectral imaging shows promise for improving uterine transplant surgery

Future Science Group today announced the publication of an article in Future Science OA demonstrating the first use of multispectral imaging in gynecology, in a uterine transplant setting.

12 Feb 2018

New faster and cheaper method developed to drug test athletes

It will now be easier, faster and cheaper to catch athletes who take performance-enhancing drugs. A new way of testing blood and urine developed by University of Waterloo researchers cuts down the time required to analyze samples from 30 minutes to 55 seconds. They're working to reduce it even further to 10 seconds per sample by using a fully automated workflow.

8 Feb 2018

ASCO's big-data, real-world health system revolutionizes future of cancer care

Future Science Group today announced the publication of an article in Future Oncology discussing the American Society of Clinical Oncology's CancerLinQ real-world, rapid learning health system.

28 Oct 2017

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Future Science Group today announced the publication of an article in Future Science OA presenting early data from a novel assay for the non-invasive detection of PD-L1 and other biomarkers in patient blood samples.

22 Sep 2017

Researchers present promising approach to create virus- and oncogene-free IPSCs

Induced pluripotent stem cells (IPSCs) hold great promise in regenerative medicine, personalized medicine and drug discovery.

24 May 2017

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

18 May 2017

Bioanalysis News and Research

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meetin

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

New biosensing platform detects SARS-CoV-2 antibodies in five minutes

Synexa Life Sciences Strengthens its Executive Team for Further Growth

Syrinx Bioanalytics Acquired by Synexa Life Sciences to Expand Scope of Bioanalysis

Synexa Life Sciences Opens New Rockville Laboratory Site in North America

Dual therapeutic potential of zapnometinib against COVID-19

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Providing quick & efficient CRO services with Sino Biological

New, rapid antibody test gives detailed information on how the immune system reacts to Covid-19

Roundworm study suggests alternatives for treatment of schizophrenia

A Light Source in Quantitative Analysis: What Role Does it Play?

Highly sensitive ELISA method for analysis of CET in plasma samples

Multi-spectral imaging shows promise for improving uterine transplant surgery

New faster and cheaper method developed to drug test athletes

ASCO's big-data, real-world health system revolutionizes future of cancer care

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Researchers present promising approach to create virus- and oncogene-free IPSCs

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

The Incredible Potential of Lipid Nanoparticles (LNPs)

Hasret Altan-Martin

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Latest News

Neuroscience eBook